Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
RINVOQ Ret Tabl 15 mg 28 Stk
Drug
Rinvoq, Retardtabletten
Rheumatoide Arthritis, Psoriasis-Arthritis, Ankylosierende Spondylitis (Morbus Bechterew), Atopische Dermatitis, Colitis ulcerosa, Morbus Crohn
07.15.0. – immunosuppressants
HAM – Human medicine
RETT – Prolonged-release tablet
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
1/20/2020
12/31/9999
Dosage strength
Rinvoq 15 mg, Retardtabletten
Rheumatoide Arthritis, Psoriasis-Arthritis, Ankylosierende Spondylitis (Morbus Bechterew), Atopische Dermatitis, Colitis ulcerosa, Morbus Crohn
01
Z – approved
Package
7680672570013
In trade from / since 1/20/2020
A/R – Authorised / referenced
28 tablet(s)
001
Z – approved
Declaration
Component
15 mg upadacitinibum
upadacitinibum hemihydricum
upadacitinibum hemihydricum
cellulosum microcristallinum
hypromellosum
mannitolum
acidum tartaricum
silica colloidalis anhydrica
magnesii stearas
poly(alcohol vinylicus)
macrogolum 3350
talcum
E 171
E 172 (nigrum)
E 172 (rubrum)
hypromellosum
mannitolum
acidum tartaricum
silica colloidalis anhydrica
magnesii stearas
poly(alcohol vinylicus)
macrogolum 3350
talcum
E 171
E 172 (nigrum)
E 172 (rubrum)
Spezialitätenliste***
SL
-
-
848.65
None
Yes
10%
No
Authorisation holder
7601001396968
AbbVie AG
Alte Steinhauserstrasse 14
6330 Cham (ZG)
Alte Steinhauserstrasse 14
6330 Cham (ZG)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.